-
Symbol
-
PLX on NYSE
-
Investment type
-
Equity / Common Stock, $0.001 par value per share
-
Latest Disclosed Shares Owned
-
4,649,599 shares
-
Security Ownership %
-
5.8%
MAK Capital Fund LP ownership in Protalix BioTherapeutics, Inc. Common Stock, $0.001 par value per share (PLX)
04 Mar 2026 - MAK Capital Fund LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,649,599 shares of Protalix BioTherapeutics, Inc. Common Stock, $0.001 par value per share (PLX).
This represents 5.8% ownership of the company.
This is the first filing by MAK Capital Fund LP disclosing ownership of Protalix BioTherapeutics, Inc. Common Stock, $0.001 par value per share (PLX).